Gut microbiota and hypertension: a bibliometric analysis of recent research (2014-2023)

Yang Jiao1, Wenxing Li1,2, Qianyi Zhang1,2

  • 1Department of Cardiology, Zunyi First People's Hospital, The Third Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.

Frontiers in Nutrition
|October 30, 2023
PubMed

Insights

Research shows a growing link between gut microbiota (GM) and hypertension (HTN). This bibliometric analysis highlights key research areas and trends in understanding this relationship for cardiovascular health.

Area of Science:

  • Cardiovascular Research
  • Microbiome Science
  • Bibliometrics

Background:

  • Hypertension (HTN) is a major global risk factor for cardiovascular diseases.
  • Gut microbiota (GM) is increasingly recognized for its therapeutic potential in cardiovascular conditions, including HTN.
  • Understanding the intricate connections between GM and HTN is crucial for advancing cardiovascular health research.

Purpose of the Study:

  • To conduct a bibliometric analysis of research on gut microbiota and hypertension.
  • To identify key research domains, influential authors, and emerging trends in this field.
  • To provide an objective summary of the primary research directions for future scientific reference.

Main Methods:

  • Bibliometric analysis of 1,730 articles published between 2014 and 2023.
  • Utilized Web of Science database for article retrieval.
  • Employed CiteSpace and VOSviewer software for data analysis.

Main Results:

  • The field of gut microbiota and hypertension research has shown significant growth from 2014-2023.
  • China leads in publication volume, while the United States leads in international collaborations.
  • Key research themes include metabolic syndrome, inflammation, short-chain fatty acids, and trimethylamine N-oxide.

Conclusions:

  • The relationship between gut microbiota and hypertension is a dynamic and expanding research area.
  • Bibliometric analysis reveals core research directions and influential contributions.
  • This study offers insights into current hotspots and future trends for researchers in GM and HTN.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
15
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
14
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
14
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
3.2K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
12